Ignite Creation Date:
2024-10-26 @ 3:37 PM
Last Modification Date:
2024-10-26 @ 3:37 PM
Study NCT ID:
NCT06545136
Status:
RECRUITING
Last Update Posted:
None
First Post:
2024-07-29
Brief Title:
Long Term Follow-up Study of Type-1 Gaucher Subjects Post FLT201 Dose GALILEO-2
Sponsor:
None
Organization:
None
Study Overview
Official Title:
A Multicenter Long-term Follow-up Study to Investigate the Safety and Durability of Response Following Dosing of an Adeno-associated Viral Vector FLT201 in Subjects With Gaucher Disease GALILEO-2
Status:
RECRUITING
Status Verified Date:
2024-08
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
No
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This is a multicenter long-term follow-up trial of participants with Gaucher disease type 1 who received FLT201 treatment in a preceding clinical trial Participants will be followed for 5 years post-treatment
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None